Skip to content

GRAFTYS

Active
Public limited company·Vervaardiging van geneesmiddelen· 9 yrs active
Quai Sur Meuse 19 ·4000 Liège, Belgium
Open bankruptcy
KBO/BCE: BE 0676.661.805
Watch Print / PDF
Age9 yrs
Staff (FTE)4.4

Summary

Conclusion

the dossier summarised in one paragraph

A bankruptcy procedure is open for GRAFTYS according to publications in the Belgian State Gazette. The 2021 annual accounts show equity of €3.96M and a net result of €-2.87M.

Based on the State Gazette, CBE and 4 annual accounts.

Bankruptcy probability (12 mo)

Checked model v1 · free for everyone

Bankruptcy opened

A bankruptcy procedure is already open, a probability score is no longer meaningful. See the insolvency timeline for the state of the procedure.

Insolvency timeline

1 events
14-06-2024
Bankruptcy Opening
Date: 10-06-2024 · Tribunal de l’entreprise de Liège, division Liège · GRAFTYS SA QUAI SUR MEUSE 19, 4000 LIEGE 1 · Publications in State Gazette ↗

Signals

Insufficient current data: the most recent filed accounts (financial year 2021) are too old to derive current signals.

Filing behaviour

From the deposit records, complete market-wide
Filing behaviour not assessed
The register records an open bankruptcy. From that point the trustee files and the ordinary seven-month rhythm no longer governs. The register carries no start date, so we cannot tell which filings fall before it: we show the facts and do not assess the behaviour.
Filed after the deadline
The financial year that closed on 31-12-2021 was due by 31-07-2022 and was filed on 26-08-2022, 26 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
How we compute the deadline
The year end is derived from 4 filed financial years, each closing on 31-12. The statutory deadline is seven months after the close of the financial year (art. 3:10 par. 1 CAC, art. 3:47 par. 7 for ASBL and foundations). Applied to the financial year that closed on 31-12-2021, that is 31-07-2022.
Deadline per financial year
Year closed Due by Filed Variance Reference
31-12-2025 31-07-2026 nothing on record not filed -
31-12-2024 31-07-2025 nothing on record not filed -
31-12-2023 31-07-2024 nothing on record not filed -
31-12-2022 31-07-2023 nothing on record not filed -
31-12-2021 31-07-2022 26-08-2022 26 d late 2022-20328034
31-12-2020 31-07-2021 14-06-2022 318 d late 2022-20060572
31-12-2019 31-07-2020 21-08-2020 21 d late 2020-43600258
31-12-2018 31-07-2019 22-08-2019 22 d late 2019-49600344

Source: the National Bank's deposit records. Those records are complete, including for years whose figures we have not read yet. Filing late covers nearly half the market and is therefore not scored; only not filing, being more than 90 days late and breaking a punctual record carry weight.

Trust signals

2 signals
Register: open bankruptcy
The KBO register records legal situation 050 for this company. This is today's state according to the register itself; the register carries no start date.
Open bankruptcy
Active bankruptcy procedure in the Belgisch Staatsblad. Claims are handled by the appointed curator.

Administrative Flags

No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

Financials

TurnoverNot published (abbreviated filing)
EBIT marginNot published (abbreviated filing)
Net result€-2.87M-143.6%
Working capital€3.18M-18.2%
Directors2

Annual accounts & ratios

Source: NBB · 2021
Annual accounts filed on 26-08-2022 with the NBB · fiscal year 2021 · volledig
€-3.00M€-2.00M€-1.00M€0Operating result 2018: €181k€181kNet result 2018: €117k€117kOperating result 2019: €-530k€-530kNet result 2019: €-544k€-544kOperating result 2020: €-1.13M€-1.13MNet result 2020: €-1.18M€-1.18MOperating result 2021: €-1.35M€-1.35MNet result 2021: €-2.87M€-2.87M2018201920202021
Operating resultNet result
EBITDA
€-1.34M
-20.2% 18-21
Net profit
€-2.87M
-143.6% 18-21
Cash flow
€-2.85M
-145.0% 18-21
Total assets
€8.27M
+6.3% 18-21
Equity
€3.96M
+23.1% 18-21
Working capital
€3.18M
-18.2% 18-21
Employees (FTE)
4
-54.6% 18-21
Staff costs
€421k
-37.4% 18-21
Income taxes
€955
- 18-21
Debt
€4.31M
-5.5% 18-21
Debt ≤ 1y
€662k
+5.4% 18-21
Debt > 1y
€238k
-11.7% 18-21
Current ratio
5.80
-19.3% 18-21
Quick ratio
5.80
-18.6% 18-21
Solvency
47.9%
+15.8% 18-21
Debt / equity
1.09
-23.2% 18-21
ROE
-72.5%
-97.9% 18-21
ROA
-34.7%
-129.1% 18-21
Interest coverage
-0.87
+95.2% 18-21
Figures by fiscal year
Fiscal year2021
Depositvolledig
Revenue-
EBITDA€-1.34M
Net profit€-2.87M
Cash flow€-2.85M
Staff costs€421k
Income taxes€955
Dividends-
Total assets€8.27M
Equity€3.96M
Debt€4.31M
of which ≤ 1y€662k
of which > 1y€238k
Working capital€3.18M
Employees (FTE)4.4
Ratios (computed)
2021
Current ratio5.80
Quick ratio5.80
Working capital ratio38.4%
Solvency47.9%
Debt / equity1.09
Long-term debt ratio0.06
Interest coverage-0.87
Gross margin-
Net margin-
ROA-34.7%
ROE-72.5%
EBITDA margin-
Days sales outstanding-
Days payable outstanding-
Inventory turnover-
Days inventory (DSI)-
Balance-sheet composition 2021
Full annual accounts
Filed balance sheet and income statement, exactly as deposited with the NBB.
Line item Code2021
Balance sheet, Assets
TOTAL ASSETS 20/58€8.27M
Fixed assets 21/28€4.43M
Intangible fixed assets 21€1.77M
Tangible fixed assets 22/27€63k
Financial fixed assets 28€2.59M
Current assets 29/58€3.84M
Stocks & contracts in progress 3€0
Amounts receivable within one year 40/41€3.17M
Cash & bank 54/58€660k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES 10/49€8.27M
Equity 10/15€3.96M
Contributions / capital 10/11€7.62M
Reserves 13€117k
Accumulated profits (losses) 14€-4.59M
Amounts payable 17/49€4.31M
Amounts payable after one year 17€238k
Amounts payable within one year 42/48€662k
Trade debts payable within one year 44€584k
Income statement
Gross operating margin 9900€-907k
Operating result 9901€-1.35M
Financial income 75€10k
Financial charges 65€1.53M
Result before taxes 9903€-2.87M
Income taxes 67/77€955
Net result for the period 9904€-2.87M
Result to be appropriated 9905€-2.87M
You're seeing the latest fiscal year only. Unlock 3 prior years (figures + ratios) with a paid plan. See plans →
Ratios computed by Checked.

Health barometer

FY 2021 · computed
0 / 100 Critical
050100
Computed from 5 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.

Unlock the full score breakdown, per-year score history and the indicative credit limit from Kantoor S.

See plans →
Computed by Checked from the NBB filing for FY 2021 and an insolvency signal from the Belgian State Gazette. Indicative, not credit advice.

Directors

Directors & mandates

Not yet read from the acts

14 acts for this company are in the Belgian State Gazette, of which we have read 0. This is therefore not a statement about the company: we have not extracted its directors from those acts yet.

Insolvency mandates

2 mandates
Role Name Tenure Source
Curator LAURENT WINKIN
RUE DES AUGUSTINS 32, 4000 LIEGE 1
10-06-2024 → present Belgian State Gazette
Curator EDOUARD FRANCK
RUE DES AUGUSTINS 32, 4000 LIEGE 1- edouard.franck@henry- mersch.be
10-06-2024 → present Belgian State Gazette

Legal Structure

NACE primary Vervaardiging van geneesmiddelen(21201)
Legal form Public limited company(014)
Incorporation08-06-2017
StatusActive
Postal code4000
First BS signal 14-06-2024
Latest BS signal 14-06-2024

Structure & network

Ownership & control

No ownership or control structure found in the sources.

For this we read shareholding and parent/subsidiary relations from the acts in the Belgian State Gazette, plus the board seats that legal entities hold in one another. Nothing of the sort is published for this company, which is common: most Belgian companies do not publish a shareholding structure.

2 court or liquidation mandates are on record for this company. Such a mandate is a fact about the company itself, not about a tie to another one: two bankruptcies handled by the same receiver are two separate cases. They are listed under Directors & mandates.

Locations & real estate

Registered office

from the Crossroads Bank
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Quai Sur Meuse 194000 Liège

Establishment units

1 location
Graftys Belgique
Quai Sur Meuse 19, 4000 LiègeVervaardiging van farmaceutische grondstoffen
since 20222.334.107.733
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Parcels1
Ground area2,628 m²
Buildings1
Building footprint2,281 m²
Volume (LiDAR)22,761 m³
Tallest building29.8 m · ±3 fl.

Real-estate footprint

Source: CBE × cadastre · address linking

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Wallonia 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
62063A0748/00D000
ProtectedMonument
Wallonia 2,628 m² 1 · 2,281 m² 29.8 m · 3 fl.
Methodology
via registered seat: 1
1 of 1 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
1 of these parcels carry protected heritage (source: regional heritage registers, Onroerend Erfgoed / patrimoine.brussels).

Publications

Lifecycle & Insolvency Signals

1 event from the State Gazette
14-06-2024
Bankruptcy Opening
Date: 10-06-2024 · Tribunal de l’entreprise de Liège, division Liège · GRAFTYS SA QUAI SUR MEUSE 19, 4000 LIEGE 1 · Publications in State Gazette ↗

Time machine: BS events + macro context

2021-2026
COVID lockdownEnergiecrisisECB hikes2021202220232024202520262024-06-14 · Bankruptcy · Opening
Macro context
2020-Q2/Q3 COVID lockdown
2022 energy crisis
2023-2024 ECB rate hikes
Legend
Bankruptcy
Interim / reorg
KBO event

Belgisch Staatsblad · acts

5 acts
Capital history · 4
15-12-2023
Capital change
24-11-2023
Capital change
27-07-2022
Capital change
29-03-2022
Capital change
Address history · 1
22-07-2022
Registered-office move
All acts · 5 updated 2 years ago
2023
15-12-2023 Capital increase of €351,492 to €12,528,980.64 Capital & shares·Peter VAN MELKEBEKE
  • €12.177.488,64 → €12.528.980,64
  • Inbreng in geld · Apport en numéraire
Notary: Peter VAN MELKEBEKE · BruxellesFirm: Berquin Notaires
24-11-2023 Capital increase of €1,717,068 to €12,177,488.64 Capital & shares·Peter VAN MELKEBEKE
  • €10.460.420,64 → €12.177.488,64
  • 2 kapitaalbewegingen in deze akte
Notary: Peter VAN MELKEBEKE · BruxellesFirm: BERQUIN NOTAIRES
2022
27-07-2022 Capital increase of €1,711,001.88 to €10,460,420.64 Capital & shares·Peter VAN MELKEBEKE
  • €8.749.418,76 → €10.460.420,64
  • Inbreng in geld · Apport en numéraire
  • 2 kapitaalbewegingen in deze akte
Notary: Peter VAN MELKEBEKE · BruxellesFirm: BERQUIN NOTAIRES
22-07-2022 Registered office moved from Charleroi to Liège Registered-office change
  • Rue d'Edimbourg 11 à 6040 Charleroi → Quai sur Meuse 19, 4000 Liège
29-03-2022 Capital increase of €800,082 to €8,420,343.30 Capital & shares·Peter VAN MELKEBEKE
  • €7.620.261,30 → €8.420.343,30
Notary: Peter VAN MELKEBEKE · BruxellesFirm: Berquin Notaires

Analysis

Snowflake analysis

financial profile on 5 axes
Health0Profitability0Solvency93Growth52Stability0
29 / 100

Fragile profile, watch health in particular.

All 5 axes are computed from data Checked has read.

Health 0
Profitability 0
Solvency 93
Growth 52
Stability 0

Ask AI about this company

Checked AI

Soon: ask questions about this dossier, risks, curator, sector comparison, answered from the official data on this page.

TryWhat are the main risks?Any recent red flags?Compare to sector peers
Coming soon

AI due-diligence brief

Checked AI

Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.

Coming soon
The brief is drafted by our AI model at Anthropic in the US, from this dossier's public data. Nothing that identifies you is sent along and we do not keep the brief. Indicative, not legal or investment advice. How it works

Credit advice

verdict per customer and amount

Should this customer buy amount X on invoice? Enter the amount and payment terms, you get an instant GREEN/AMBER/RED verdict, with a suggested ceiling and concrete conditions.

Based on official sources (NBB, CBE, State Gazette). Indicative, not credit advice.

Similar

Similar companies

Comparable size, same sector

Company registry

Company registry (CBE)

Crossroads Bank
Activities
Vervaardiging van geneesmiddelen21201Vervaardiging van geneesmiddelen21201
Primary activity highlighted.
Names & trade names
Legal nameFR GRAFTYS
Registered office
Quai Sur Meuse 19
4000 Liège, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.